Systematic review: Scores used to predict outcomes in acute severe ulcerative colitis

Author:

Kayal Maia1ORCID,Meringer Hadar1,Martin Lily2,Colombel Jean Frederic1ORCID

Affiliation:

1. Henry D. Janowitz Division of Gastroenterology, Susan and Leonard Feinstein Inflammatory Bowel Disease Center Icahn School of Medicine at Mount Sinai New York New York USA

2. Library Education & Research Services Icahn School of Medicine at Mount Sinai New York New York USA

Abstract

SummaryBackgroundApproximately 25% of patients with ulcerative colitis (UC) experience an episode of acute severe ulcerative colitis (ASUC) during their disease course. Management and risk stratification of these patients is a great unmet medical need.AimTo review the literature systematically all currently available scores used to predict outcomes in patients with ASUC.MethodsWe executed a comprehensive search comprising both index terms and keywords in MEDLINE, Embase and Cochrane CENTRAL databases. We included observational cohort studies that reported on scoring indices to predict outcomes in patients admitted with ASUC defined by the Truelove and Witts criteria. We excluded studies that reported on risk factors of outcomes in patients with ASUC in isolation, not in the context of a score.ResultsThe literature search identified 8729 studies, of which 18 were chosen to report 19 scores. Most scores included clinical and/or laboratory components. Two included imaging assessed by abdominal plain films; five included endoscopy assessed by the Ulcerative Colitis Endoscopic Index of Severity (UCEIS) or the Mayo Score. Outcomes included intravenous corticosteroid response and short‐ and long‐term colectomy. The reported positive predictive value of the scores ranged from 70 to 100% for their respective outcome.DiscussionMultiple scores exist for the prediction of outcomes in patients with ASUC, although each has limitations. A new score that reflects the current standard of care is needed to inform risk stratification in patients with ASUC.

Publisher

Wiley

Subject

Pharmacology (medical),Gastroenterology,Hepatology

Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Letter: ‘No first among equals’—Authors' reply;Alimentary Pharmacology & Therapeutics;2023-11-06

2. Letter: ‘No first among equals’;Alimentary Pharmacology & Therapeutics;2023-11-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3